Serum type III procollagen aminopeptide for assessing liver damage in methotrexate-treated psoriatic patients
- 1 October 1996
- journal article
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 135 (4) , 538-544
- https://doi.org/10.1046/j.1365-2133.1996.d01-1036.x
Abstract
No abstract availableThis publication has 20 references indexed in Scilit:
- Structure of the Extracellular Matrix in Normal and Fibrotic Liver: Collagens and GlycoproteinsSeminars in Liver Disease, 1990
- Methotrexate in psoriasis: Revised guidelinesJournal of the American Academy of Dermatology, 1988
- The response evaluation of bone metastases in mammary carcinoma. The value of radiology, scintigraphy, and biochemical markers of bone metabolismCancer, 1987
- Type III Collagen Aminopropeptide Levels in Serum of Patients With Progressive Systemic SclerodermaJournal of Investigative Dermatology, 1986
- PROCOLLAGEN-III-PEPTIDE AND HYRERTHYROIDISMThe Lancet, 1986
- The N-terminal propeptide of collagen type III in serum as a prognostic indicator in primary biliary cirrhosisJournal of Hepatology, 1986
- The N-Terminal Propeptide of Collagen Type III in Serum Reflects Activity and Degree of Fibrosis in Patients with Chronic Liver Disease†Hepatology, 1984
- The Blue Glass and the Predictive Value of Serum Amino-Terminal Propeptide of Type III Procollagen as a Marker of Liver FibrosisHepatology, 1984
- Ultrastructural identification of extension aminopropeptides of type I and III collagens in human skin.Proceedings of the National Academy of Sciences, 1981
- Biosynthesis of ProcollagenAnnual Review of Biochemistry, 1978